Clofutriben for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Nov 2025: Trial started, NCT07296484
  2. 22 Dec 2025: Trial registered, NCT07296484

The trials

NCT07296484: Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

State
Under way
Phase
Phase 2
People
1,500 planned
Started
29 Nov 2025
Primary completion
31 Dec 2027
Arms
Dose 1, Dose 2, Dose 3, Dose 4
Results
None posted
  1. 29 Nov 2025: Trial started
  2. 22 Dec 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.